The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - BD Biosciences; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ono Pharmaceutical
Consulting or Advisory Role - Kyowa Hakko Kirin; MSD
Clinicopathological features of program death ligand-1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
 
Akihito Kawazoe
No Relationships to Disclose
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Novartis; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Yasutoshi Kuboki
Honoraria - Bayer; Taiho Pharmaceutical
 
Hideaki Bando
Research Funding - AstraZeneca; Sysmex
 
Takashi Kojima
Honoraria - Amgen
Research Funding - Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Atsushi Ochiai
Research Funding - Amgen (Inst); Bayer (Inst); Bayer Yakuhin (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Janssen (Inst); Merck Serono (Inst); Otsuka (Inst); Takeda (Inst)
 
Yosuke Togashi
No Relationships to Disclose
 
Hiroyoshi Nishikawa
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Zenyaku Kogyo (Inst)
 
Toshihiko Doi
Consulting or Advisory Role - Amgen; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD; Nippon Boehringer Ingelheim; Novartis
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Takeshi Kuwata
No Relationships to Disclose